Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

THE FLT3/FLK2 receptor tyrosine kinase is closely related to two receptors, c-Kit and c-Fms, which function with their respective ligands, Kit ligand and macrophage colony-stimulating factor to control differentiation of haematopoietic and non-haematopoietic cells1–5. FLT3/FLK2 is thought to be present on haematopoietic stem cells and found in brain, placenta and testis3–5. We have purified to homogeneity and partially sequenced a soluble form of the FLT3/FLK2 ligand produced by mouse thymic stromal cells. We isolated several mouse and human complementary DNAs that encode polypeptides with identical N termini and different C termini. Some variants contain hydrophobic transmembrane segments, suggesting that processing may be required to release soluble lig-and. The purified ligand enhances the response of mouse stem cells and a primitive human progenitor cell population to other growth factors such as interleukins IL-3 and IL-6 and to granulocyte-macrophage colony-stimulating factor, and also stimulates fetal thymocytes.

[1]  J. Gibbs.  Ras C-terminal processing enzymes—New drug targets? , 1991, Cell.

[2]  J. Pandit,et al.  Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. , 1992, Science.

[3]  G. Zurawski,et al.  Receptors for interleukin‐13 and interleukin‐4 are complex and share a novel component that functions in signal transduction. , 1993, The EMBO journal.

[4]  A. Ullrich,et al.  Growth factor signaling by receptor tyrosine kinases , 1992, Neuron.

[5]  D. Birnbaum,et al.  Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. , 1993, Blood.

[6]  C. Sherr.  Colony-stimulating factor-1 receptor. , 1990, Blood.

[7]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[8]  D. Birnbaum,et al.  Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. , 1993, Oncogene.

[9]  I. Weissman,et al.  Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.

[10]  I. Weissman,et al.  The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Sprang,et al.  Cytokine structural taxonomy and mechanisms of receptor engagement , 1993 .

[12]  J. Bazan.  Genetic and structural homology of stem cell factor and macrophage colony-stimulating factor , 1991, Cell.

[13]  O. Witte.  Steel locus defines new multipotent growth factor , 1990, Cell.

[14]  G. Zurawski,et al.  Receptor antagonist and selective agonist derivatives of mouse interleukin‐2. , 1992, The EMBO journal.

[15]  R. de Waal Malefyt,et al.  Untransfected and SV40-transfected fetal and postnatal human thymic stromal cells. Analysis of phenotype, cytokine gene expression and cytokine production. , 1993, Thymus.

[16]  R. de Waal Malefyt,et al.  Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Steinmetz,et al.  IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo , 1985, Cell.

[18]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Birnbaum,et al.  Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. , 1991, Oncogene.

[20]  A. Zlotnik,et al.  Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. , 1992, Journal of immunology.